RNA Technology Shows Promise in Improving Diabetes Treatment

A targeted RNA therapy has demonstrated the ability to boost VEGF-A in transplanted beta cells, leading to accelerated blood-vessel growth and improved islet survival and glucose control for Type 1 diabetes.